Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,164 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Changes in chronic myeloid leukemia treatment modalities and outcomes after introduction of second-generation tyrosine kinase inhibitors as first-line therapy: a multi-institutional retrospective study by the CML Cooperative Study Group.
Iriyama N, Iwanaga E, Kimura Y, Watanabe N, Ishikawa M, Nakayama H, Sato E, Tabayashi T, Mitsumori T, Takaku T, Nakazato T, Tokuhira M, Fujita H, Ando M, Hatta Y, Kawaguchi T. Iriyama N, et al. Among authors: fujita h. Int J Hematol. 2024 Jul;120(1):60-70. doi: 10.1007/s12185-024-03758-4. Epub 2024 Apr 8. Int J Hematol. 2024. PMID: 38587692
Clinical management of second-generation tyrosine kinase inhibitor therapy in patients with newly diagnosed chronic myeloid leukemia in the chronic phase, focusing on age and dose effects.
Tokuhira M, Kimura Y, Tabayashi T, Watanabe N, Tsuchiya S, Takaku T, Iriyama N, Sato E, Nakazato T, Mitsumori T, Ishikawa M, Fujita H, Kizaki M, Ando M, Hatta Y, Iwanaga E, Kawaguchi T. Tokuhira M, et al. Among authors: fujita h. Int J Hematol. 2023 Aug;118(2):210-220. doi: 10.1007/s12185-023-03606-x. Epub 2023 May 2. Int J Hematol. 2023. PMID: 37129800
Global Delphi consensus on treatment goals for generalised pustular psoriasis.
Barker JN, Casanova E, Choon SE, Foley P, Fujita H, Gonzalez C, Gooderham M, Marrakchi S, Puig L, Romiti R, Thaçi D, Zheng M, Strober B; Partnering for Innovation and Excellence in Rare Skin Diseases (PIONEERS®) Working Group and the DELPHI Panel. Barker JN, et al. Among authors: fujita h. Br J Dermatol. 2025 Jan 23:ljae491. doi: 10.1093/bjd/ljae491. Online ahead of print. Br J Dermatol. 2025. PMID: 39844356
Transcriptomic landscape of hyperthyroidism in mice overexpressing thyroid-Stimulating hormone.
Yamauchi I, Sugawa T, Hakata T, Yoshizawa A, Kita T, Kishimoto Y, Kimura S, Sakurai A, Kosugi D, Fujita H, Okamoto K, Ueda Y, Fujii T, Taura D, Sakane Y, Yasoda A, Inagaki N. Yamauchi I, et al. Among authors: fujita h. iScience. 2024 Dec 10;28(1):111565. doi: 10.1016/j.isci.2024.111565. eCollection 2025 Jan 17. iScience. 2024. PMID: 39811643 Free PMC article.
Managing sleep issues in Parkinson's disease: an up-to-date review.
Suzuki K, Fujita H, Kobayashi S. Suzuki K, et al. Among authors: fujita h. Expert Rev Neurother. 2025 Jan 10:1-16. doi: 10.1080/14737175.2025.2450789. Online ahead of print. Expert Rev Neurother. 2025. PMID: 39789992 Free article. Review.
4,164 results